Literature DB >> 21499130

Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro.

Jianping Huang1, Qiong J Wang, Shicheng Yang, Yong F Li, Mona El-Gamil, Steven A Rosenberg, Paul F Robbins.   

Abstract

In addition to the direct killing of tumor cells, radiation therapy can alter the balance of immune cells in vivo due to the differential radiosensitivity of different cell types. The addition of adjuvant radiation therapy before adoptive cell transfer therapy has been shown to enhance antitumor responses in both mouse models and clinical trials. This study examines the effects of in vitro irradiation on the phenotype and function of human antigen-presenting cells. The results indicated that irradiation upregulated CD70 expression on both B cells and mature dendritic cells (DCs). Expression of CD70 on mature DCs was enhanced in a dose-dependent manner, whereas under the same conditions, no significant upregulation of CD80, CD86, or CD40 was observed. The levels of expression of CD70 induced on mature DC by irradiation correlated highly with the ability of those cells to stimulate T-cell proliferation and interferon-γ production. Furthermore, significant reductions in T-cell proliferation and interferon-γ production were seen when CD70 expression on DCs was partially reduced using shRNA, as well as when DCs were incubated with a blocking anti-CD70 antibody. Radiation therapy may therefore enhance T-cell activation in vivo through the CD27 pathway by virtue of its ability to upregulate the expression of CD70 on antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499130      PMCID: PMC3094909          DOI: 10.1097/CJI.0b013e318216983d

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  27 in total

1.  IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells.

Authors:  S Skov; M Bonyhadi; N Odum; J A Ledbetter
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

2.  IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells.

Authors:  P Kaliński; C M Hilkens; A Snijders; F G Snijdewint; M L Kapsenberg
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

Review 3.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.

Authors:  Timothy N J Bullock; Hideo Yagita
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

5.  Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors:  Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  Science       Date:  2002-09-19       Impact factor: 47.728

6.  Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells.

Authors:  Claudia Wrzesinski; Chrystal M Paulos; Andrew Kaiser; Pawel Muranski; Douglas C Palmer; Luca Gattinoni; Zhiya Yu; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunother       Date:  2010-01       Impact factor: 4.456

Review 7.  Costimulation of T cells by OX40, 4-1BB, and CD27.

Authors:  Michael Croft
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

8.  Expression of the murine CD27 ligand CD70 in vitro and in vivo.

Authors:  Kiki Tesselaar; Yanling Xiao; Ramon Arens; Gijs M W van Schijndel; Danita H Schuurhuis; Reina E Mebius; Jannie Borst; René A W van Lier
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.

Authors:  Yu-Pei Liao; Chun-Chieh Wang; Lisa H Butterfield; James S Economou; Antoni Ribas; Wilson S Meng; Keisuke S Iwamoto; William H McBride
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.

Authors:  R Manetti; P Parronchi; M G Giudizi; M P Piccinni; E Maggi; G Trinchieri; S Romagnani
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  14 in total

1.  Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis.

Authors:  Theres Lindgren; Torgny Stigbrand; Katrine Riklund; Lennart Johansson; David Eriksson
Journal:  Tumour Biol       Date:  2012-02-10

2.  Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.

Authors:  Jacob S Bowers; Michelle H Nelson; Sreenath Kundimi; Stefanie R Bailey; Logan W Huff; Kristina M Schwartz; David J Cole; Mark P Rubinstein; Chrystal M Paulos
Journal:  Clin Cancer Res       Date:  2015-04-22       Impact factor: 12.531

3.  The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.

Authors:  Michael Spiotto; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Sci Immunol       Date:  2016-09-30

4.  Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells.

Authors:  Matthias Wölfl; Philip D Greenberg
Journal:  Nat Protoc       Date:  2014-03-27       Impact factor: 13.491

Review 5.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

Review 6.  Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.

Authors:  Xue Han; Matthew D Vesely
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-20       Impact factor: 6.813

7.  CD70, a novel target of CAR T-cell therapy for gliomas.

Authors:  Linchun Jin; Haitao Ge; Yu Long; Changlin Yang; Yifan Emily Chang; Luyan Mu; Elias J Sayour; Gabriel De Leon; Qiong J Wang; James C Yang; Paul S Kubilis; Hongbo Bao; Songsong Xia; Dunyue Lu; Yingjun Kong; Li Hu; Yujiao Shang; Chencheng Jiang; Jing Nie; Shimin Li; Yunhe Gu; Jiahang Sun; Duane A Mitchell; Zhiguo Lin; Jianping Huang
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

8.  The inducible costimulator augments Tc17 cell responses to self and tumor tissue.

Authors:  Michelle H Nelson; Sreenath Kundimi; Jacob S Bowers; Carolyn E Rogers; Logan W Huff; Kristina M Schwartz; Krishnamurthy Thyagarajan; Elizabeth C Little; Shikhar Mehrotra; David J Cole; Mark P Rubinstein; Chrystal M Paulos
Journal:  J Immunol       Date:  2015-01-09       Impact factor: 5.422

Review 9.  T-cell receptor gene therapy--ready to go viral?

Authors:  Terhi Karpanen; Johanna Olweus
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

Review 10.  Harnessing the Microbiome to Enhance Cancer Immunotherapy.

Authors:  Michelle H Nelson; Marshall A Diven; Logan W Huff; Chrystal M Paulos
Journal:  J Immunol Res       Date:  2015-05-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.